Nova Patents
AT307123T

Synthesis of epothilones, intermediates thereto and analogues therof

Abstract

(57) Summary book invention offers the convergence method for preparing EPO チロン A and B which can be used for the medical treatment of Gang who produced Gang and a drug-resistant phenotype, デオキシエポチロン, B, and its analog. Moreover, the intermediate field which can be used in order to prepare the above-mentioned EPO チロン are also offered.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

77 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
7594798United States of AmericaP
9231998United States of AmericaP
9773398United States of AmericaP
9904008United States of AmericaW

Members77

Family members, oldest first
DocumentOfficeKind
CA2273083A1CanadaA1
WO9901124A1World Intellectual Property Organization (WIPO)A1
AU5792998AAustraliaA
ZA9711282BSouth AfricaB
WO9901124A9World Intellectual Property Organization (WIPO)A9
ZA991497BSouth AfricaB
CA2322157A1CanadaA1
WO9943653A1World Intellectual Property Organization (WIPO)A1
AU2785899AAustraliaA
EP0977563A1European Patent Office (EPO)A1
EP1058679A1European Patent Office (EPO)A1
US6204388B1United States of AmericaB1
EP0977563A4European Patent Office (EPO)A4
US6242469B1United States of AmericaB1
JP2001507716AJapanA
US6284781B1United States of AmericaB1
CA2401800A1CanadaA1
WO0164650A2World Intellectual Property Organization (WIPO)A2
AU4337201AAustraliaA
US6300355B1United States of AmericaB1
IL138113D0IsraelD0
US6316630B1United States of AmericaB1
US2002002194A1United States of AmericaA1
JP2002504540AJapanA
US6369234B1United States of AmericaB1
WO0164650A3World Intellectual Property Organization (WIPO)A3
US2002058286A1United States of AmericaA1
US2002058817A1United States of AmericaA1
EP1058679A4European Patent Office (EPO)A4
TW504511BTaiwan Province of ChinaB
MXPA00008365AMexicoA
EP1259490A2European Patent Office (EPO)A2
AU756699B2AustraliaB2
AU758526B2AustraliaB2
US2003069277A1United States of AmericaA1
US2003105330A1United States of AmericaA1
US2003125362A1United States of AmericaA1
US6603023B2United States of AmericaB2
US2003171596A1United States of AmericaA1
NZ506742ANew ZealandA
US2003208080A1United States of AmericaA1
US6656961B2United States of AmericaB2
JP2004500388AJapanA
US2004019089A1United States of AmericaA1
EP1386922A2European Patent Office (EPO)A2
US2004044221A1United States of AmericaA1
EP1386922A3European Patent Office (EPO)A3
US6723854B2United States of AmericaB2
US2004102495A1United States of AmericaA1
US6828340B2United States of AmericaB2
US2004260098A1United States of AmericaA1
US6849651B2United States of AmericaB2
US2005033059A1United States of AmericaA1
US2005043376A1United States of AmericaA1
US6867305B2United States of AmericaB2
EP0977563B1European Patent Office (EPO)B1
EP1058679B1European Patent Office (EPO)B1
AT307123TThis recordAustriaT
ATE307123T1AustriaT1
US6965034B2United States of AmericaB2
US6972335B2United States of AmericaB2
DE69734362D1GermanyD1
DE69927790D1GermanyD1
DE69734362T2GermanyT2
DE69927790T2GermanyT2
IL138113AIsraelA
US2008004450A1United States of AmericaA1
JP2009298816AJapanA
US7750164B2United States of AmericaB2
US2010240721A1United States of AmericaA1
JP4579351B2JapanB2
USRE41990EUnited States of AmericaE
US2011263663A1United States of AmericaA1
EP1386922B1European Patent Office (EPO)B1
CA2322157CCanadaC
CA2273083CCanadaC
US8481575B2United States of AmericaB2